The effect of dose on safety, tolerability, and immunogenicity of ACAM2000 smallpox vaccine in adults without previous smallpox vaccination
Phase of Trial: Phase II
Latest Information Update: 26 Feb 2018
At a glance
- Drugs ACAM 2000; Smallpox vaccine
- Indications Smallpox
- Focus Adverse reactions; Pharmacodynamics
- 30 Sep 2008 Primary outcome added as reported by ClinicalTrials.gov.
- 30 Sep 2008 Study completion date has changed from Mar 2003 to Nov 2003 as reported by ClinicalTrials.gov
- 30 Sep 2008 Planned number of patients changed from 350 to 353 as reported by ClinicalTrials.gov.